Epidemic cover art

Epidemic

"The sequel to Kileak: The DNA Imperative, Epidemic drops players into a world plagued by a deadly disease: The Gigari virus."

Genki·Sony Music Entertainment Japan·City Connection·Sony Computer Entertainment· December 29, 1995· Main Game
40
Critic Score
1 reviews
40
User Score
1 ratings

The sequel to Kileak: The DNA Imperative, Epidemic drops players into a world plagued by a deadly disease: The Gigari virus. Having spread across the globe, it has forced the remnants of human civilization into hiding underground. Home to humanity is Neural City, which is controlled by the Byflos Group, who hold the threat of shutting off all life support over the heads of the city's denizens. As Masao Coda, a member of the Del Sol liberation group, you must use your Protect Armor suit to engage the Byflos Group and its many robotic minions, rescue your infected girlfriend from certain death at the hands of the virus, and eventually, save humanity.

Released 29 December 1995 for PlayStation, PlayStation Portable and PlayStation 3 by Genki, published by Sony Music Entertainment Japan and City Connection. Rated E by ESRB, 12 by USK.

Epidemic screenshots

Epidemic screenshot 1
Epidemic screenshot 2

Games like Epidemic

Epidemic trailer and videos

Gameplay Video
Gameplay Video

Epidemic screenshots

Epidemic screenshot 1
Epidemic screenshot 2

Artwork & Box Art

Epidemic artwork 1
Epidemic artwork 2
Epidemic artwork 3
PlayStation
Standard
NA
Jun 14, 1996
PlayStation
Standard
EU
Jun 14, 1996
PlayStation
Standard
JP
Dec 29, 1995
PlayStation Portable
Standard
JP
Sep 16, 2015
Digital Compatibility Release
PlayStation 3
Standard
JP
Sep 16, 2015
Digital Compatibility Release
Critic Score
40 /100
Generally Unfavorable
Based on 1 professional review
Aggregated from professional game critics and publications.
User Score
40 /100
Generally Unfavorable
Based on 1 rating
Aggregated from player ratings across platforms worldwide.
Score Comparison
Critics
40
Users
40
Score Guide
90–100
Universal Acclaim
75–89
Generally Favorable
50–74
Mixed or Average
20–49
Generally Unfavorable
CriticsUsers
0–19
Overwhelming Dislike